Published in Drugs on February 01, 1996
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer. Eur J Clin Pharmacol (2014) 0.81
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs (1982) 3.34
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs (1988) 2.94
Midazolam. A review of its pharmacological properties and therapeutic use. Drugs (1984) 2.60
Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1990) 2.29
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 2.26
Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs (1985) 2.26
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs (1977) 2.17
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs (1978) 2.12
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1993) 1.95
Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.93
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1982) 1.87
Pyrazolone derivatives. Drugs (1986) 1.72
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs (1978) 1.72
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1983) 1.71
Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.69
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.69
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1984) 1.65
Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.64
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs (1981) 1.64
Metoclopramide: a review of its pharmacological properties and clinical use. Drugs (1976) 1.63
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.56
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs (1997) 1.52
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1984) 1.52
Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs (1977) 1.52
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1978) 1.48
Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs (1997) 1.46
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs (1995) 1.45
Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs (1978) 1.44
Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs (1995) 1.43
Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs (1980) 1.43
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs (1988) 1.41
Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs (1978) 1.40
Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1994) 1.40
Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs (1975) 1.38
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1978) 1.37
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1989) 1.35
Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs (1996) 1.34
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs (1981) 1.33
Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs (1979) 1.32
Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs (1993) 1.30
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1979) 1.29
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1984) 1.26
Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs (1978) 1.23
Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs (1980) 1.22
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs (1978) 1.22
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1982) 1.22
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs (1975) 1.21
Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs (1974) 1.18
Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs (1987) 1.17
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs (1983) 1.17
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1976) 1.16
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs (1987) 1.16
Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1978) 1.14
Butorphanol: a review of its pharmacological properties and therapeutic efficacy. Drugs (1978) 1.13
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs (1981) 1.13
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs (1990) 1.12
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs (1983) 1.12
Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs (1976) 1.12
Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1981) 1.11
Xamoterol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs (1988) 1.11
Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs (1984) 1.11
Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs (1983) 1.11
Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer. Drugs (1976) 1.10
Diltiazem. A review of its pharmacological properties and therapeutic efficacy. Drugs (1985) 1.10
Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs (1982) 1.10
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs (1990) 1.09
Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1979) 1.09
Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs (1984) 1.08
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs (1998) 1.08
Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs (1976) 1.08
Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs (1977) 1.08
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging (1995) 1.07
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1986) 1.06
Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs (1992) 1.04
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs (1979) 1.04
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs (1994) 1.04
Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging (1995) 1.03
Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy. Drugs (1976) 1.01
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1993) 1.01
Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1983) 1.01
Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders. Drugs (1991) 1.00
Beclomethasone dipropionate: II: Allergic rhinitis and other conditions. Drugs (1975) 1.00
Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. Drugs (1978) 1.00
Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS). Drugs (1992) 0.99
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Drugs (1989) 0.99
Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1992) 0.98
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs (1984) 0.98
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs (1990) 0.98
Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs (1977) 0.97
Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease. Drugs (1996) 0.97
Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1977) 0.97
Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Drugs (1995) 0.97